CHOP Cancer Center Team Members Present at Prestigious International Conference
Published on in CHOP News
Nine CHOP clinicians and researchers made presentations at SIOP 2020.
Cancer Center News and Updates
1 - 10 of 246
CHOP Participates in a Multi-institutional Clinical Trial Leading to First-Ever Therapy for Neurofibromatosis Type 1
Published on in CHOP News
New therapy shrinks tumors associated with NF1 and improves quality of life.
CHOP Researchers Use Precision Medicine to Reverse Severe Lymphatic Disorder in a Patient with KLA
Published on in CHOP News
Using genetic sequencing and targeted treatment, CHOP researchers resolved a severe lymphatic disorder in a young woman with KLA, a complex and rare disorder.
Two CHOP Physicians Present at PTEN Symposium
Published on in CHOP News
Drs. Adams and MacFarland among select group of conference speakers.
Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19
Published on in CHOP News
CHOP researchers show convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
Theodore Laetsch Joins Children’s Hospital of Philadelphia to Launch Very Rare Malignant Tumors Program
Published on in CHOP News
A national leader in pediatric oncology research and treatment, Dr. Laetsch will also lead CHOP’s Developmental Therapeutics Program.
How to Build and Maintain a Child’s Resilience
Published on in Cancer Connections
Whether at home or in the hospital, these strategies can assist children to recover and adapt in difficult situations.
New Treatment Shows Success in High-Risk Solid Tumors
Published on in CHOP News
The CHOP-engineered therapy overcomes common drug resistance and has potential to elicit fewer toxicities than most cancer treatments.
2020 Guidelines for Participation in School for Oncology Patients
Published on in Cancer Connections
Learn some general principles about returning to school after COVID-19 for cancer patients and their caregivers.
New Computational Model by CHOP Researchers Identifies Noncoding Mutations Across Five Pediatric Cancers
Published on in CHOP News
In a study in Science Advances, CHOP researchers describe a new algorithm that identifies mutations in the 98% of the human genome that does not code for genes.